Correlation Between Pharma Mar and Iberpapel Gestion
Can any of the company-specific risk be diversified away by investing in both Pharma Mar and Iberpapel Gestion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharma Mar and Iberpapel Gestion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharma Mar SA and Iberpapel Gestion SA, you can compare the effects of market volatilities on Pharma Mar and Iberpapel Gestion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharma Mar with a short position of Iberpapel Gestion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharma Mar and Iberpapel Gestion.
Diversification Opportunities for Pharma Mar and Iberpapel Gestion
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pharma and Iberpapel is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pharma Mar SA and Iberpapel Gestion SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iberpapel Gestion and Pharma Mar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharma Mar SA are associated (or correlated) with Iberpapel Gestion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iberpapel Gestion has no effect on the direction of Pharma Mar i.e., Pharma Mar and Iberpapel Gestion go up and down completely randomly.
Pair Corralation between Pharma Mar and Iberpapel Gestion
Assuming the 90 days trading horizon Pharma Mar SA is expected to generate 5.47 times more return on investment than Iberpapel Gestion. However, Pharma Mar is 5.47 times more volatile than Iberpapel Gestion SA. It trades about -0.01 of its potential returns per unit of risk. Iberpapel Gestion SA is currently generating about -0.14 per unit of risk. If you would invest 7,435 in Pharma Mar SA on August 26, 2024 and sell it today you would lose (85.00) from holding Pharma Mar SA or give up 1.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharma Mar SA vs. Iberpapel Gestion SA
Performance |
| Timeline |
| Pharma Mar SA |
| Iberpapel Gestion |
Pharma Mar and Iberpapel Gestion Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharma Mar and Iberpapel Gestion
The main advantage of trading using opposite Pharma Mar and Iberpapel Gestion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharma Mar position performs unexpectedly, Iberpapel Gestion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iberpapel Gestion will offset losses from the drop in Iberpapel Gestion's long position.| Pharma Mar vs. Laboratorios Farmaceuticos ROVI | Pharma Mar vs. Atrys Health SL | Pharma Mar vs. Oryzon Genomics SA |
| Iberpapel Gestion vs. Miquel y Costas | Iberpapel Gestion vs. Vidrala SA | Iberpapel Gestion vs. Grupo Catalana Occidente | Iberpapel Gestion vs. Construcciones y Auxiliar |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |